RECCE PHARMACEUTICALS LTD — Share Issue/Capital Change 2024

Apr 15, 2024

Announcement Summary

Entity name

RECCE PHARMACEUTICALS LTD

Announcement Type

New announcement

Date of this announcement

Tuesday April 16, 2024

The +securities to be quoted are:

Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

The Company has issued 250,000 fully paid ordinary shares to a consultant for services provided to the Company over a one year term in lieu of a cash payment.

Total number of +securities to be quoted

ASX +securitycode	Security description	Number of +securities tobe quoted	Issue date
RCE	ORDINARY FULLY PAID	250,000	16/04/2024

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

1.1 Name of entity

RECCE PHARMACEUTICALS LTD

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ACN

Registration number

124849065

1.3 ASX issuer code

RCE

1.4 The announcement is 1.5 Date of this announcement New announcement

16/4/2024

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

2.2 The +class of +securities to be quoted is: Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS? No

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

The Company has issued 250,000 fully paid ordinary shares to a consultant for services provided to the Company over a one year term in lieu of a cash payment.

2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an

Appendix 3B

Additional +securities to be quoted in an existing class

ASX +security code and description

RCE : ORDINARY FULLY PAID

Issue date

16/4/2024

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Issue details

Number of +securities to be quoted

250,000

Are the +securities being issued for a cash consideration?

No

Please describe the consideration being provided for the +securities

The shares are being issued to pay for services rendered. The estimated value of the consideration per share is based on the closing price of RCE shares on 15 April 2024 being $0.495 per share.

Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted

0.495000

Any other information the entity wishes to provide about the +securities to be quoted

The purpose(s) for which the entity is issuing the securities

To pay for services rendered

Please provide additional details

The shares are being issued for the provision of services performed including market analysis and research, strategic planning and advisory, investor relations support and stakeholder engagement over a one year term in lieu of a cash payment.

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity willcomprise:
The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital ifother Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.
4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the+securities subject of this application)
ASX +security code and description	Total number of+securities on issue
RCE : ORDINARY FULLY PAID	203,951,863
4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description	Total number of+securities on issue
RCEAH : PERFORMANCE SHARES	8,754,423
RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56	435,000
RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	1,125,000
RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56	8,415,000

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No

5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1?

No

5.2b Are any of the +securities being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? Yes

5.2b.1 How many +securities are being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1?

5.2c Are any of the +securities being issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No